Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: A Phase I Study of SNH-119014 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase I clinical trial update for SNH-119014 in healthy volunteers recruiting for a study on hemoglobinopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SNH-119014

Snippet

Sponsor: ScinnoHub Pharmaceutical Co., Ltd. | Conditions: Hemoglobinopathy | Phase 1 | Status: RECRUITING